文献速递乳房整形与再造显微修复重建

大网膜脂肪增强游离皮瓣在自体乳房再造中减轻术后疼痛

Minimizing Postoperative Pain in Autologous Breast Reconstruction With the Omental Fat-Augmented Free Flap.
PubMed 文献 · Ann Plast Surg · 2022-02-21

回顾性分析2019至2021年14例(23侧)接受大网膜脂肪增强游离皮瓣(O-FAFF)自体乳房再造的患者,并与传统游离腹部组织移植患者的历史队列比较。O-FAFF组术后第1、2、3天平均疼痛评分及阿片类药物用量均显著低于对照组(P<0.05),止吐药用量为3.5剂 vs 4.8剂(P=0.6),无并发症,患者满意度100%。

要点

  • O-FAFF组术后第1、2、3天平均疼痛评分分别为3.1、2.8、2.1,显著低于传统腹部游离组织移植对照组(P<0.05)。
  • O-FAFF组住院期间阿片类药物总用量平均79.4 mg(口服吗啡当量),术后第1、2、3天平均用量分别为24.3、21.9、6.2 mg。
  • O-FAFF组止吐药平均用量3.5剂,对照组4.8剂,差异无统计学显著(P=0.6)。

核心结论

  • O-FAFF被证明是自体乳房再造的一种可行方法。
  • 早期系列患者接受O-FAFF再造提示供区并发症较低,表现为术后疼痛评分较低和阿片类止痛药用量较少。

研究设计与样本

  • 回顾性分析2019年至2021年接受O-FAFF的患者。
  • 共14例患者接受O-FAFF乳房再造,代表23侧乳房。
  • 将O-FAFF组结果与接受传统游离腹部组织移植乳房再造的对照组患者进行比较。

主要发现

  • 患者平均年龄48.5岁(±2.3岁),平均体重指数22.6 kg/m²(±1.09 kg/m²),平均随访232天(±51天)。
  • 平均乳房切除标本重量245.6 g(±30.2 g),平均O-FAFF重量271 g(±31.7 g)。
  • 术后第1、2、3天平均疼痛评分分别为3.1(±0.28)、2.8(±0.21)、2.1(±0.35)。
  • 术后第1、2、3天阿片类药物平均用量(口服吗啡当量)分别为24.3(±5.5)、21.9(±4.6)、6.2(±2.4)mg;住院期间总用量79.4 mg(±11.1 mg)。
  • O-FAFF组平均疼痛评分和阿片类药物用量显著低于既往发表的游离腹部组织移植自体乳房再造队列(P<0.05);O-FAFF组止吐药平均用量3.5剂 vs 对照组4.8剂(P=0.6)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The omental fat-augmented free flap (O-FAFF) is a recently developed technique for autologous breast reconstruction. Our aim of the study is to evaluate the outcomes of our early case series. We assess the O-FAFF donor site morbidity in terms of postoperative pain, narcotic, and antiemetic use. METHODS: A retrospective analysis of patients undergoing O-FAFF from 2019 to 2021 was performed. Patients were evaluated for demographic data, operative time, hospital course, and complications. Mean pain scores (1-10 scale) and narcotic pain medication use in oral morphine equivalents and doses of antiemetic medications during their hospital course were analyzed. We compared outcomes of our O-FAFF group with those of a control group of patients who underwent breast reconstruction with traditional free abdominal tissue transfer. RESULTS: A total of 14 patients underwent O-FAFF breast reconstruction, representing 23 breasts. Patients had an average age of 48.5 years (±2.3 years) and body mass index of 22.6 kg/m 2 (±1.09 kg/m 2 ). Average follow-up was 232 days (±51 days). Average mastectomy weight was 245.6 g (±30.2 g) and average O-FAFF weight was 271 g (±31.7 g). Average pain scores on postoperative day 1 (POD1), POD2, and POD3 were 3.1 (±0.28), 2.8 (±0.21), and 2.1 (±0.35), respectively. The average narcotic use by patients in oral morphine equivalents on POD1, POD2, and POD3 are 24.3 (±5.5), 21.9 (±4.6), and 6.2 (±2.4), respectively. Total narcotic use during hospital stay was 79.4 mg (±11.1 mg). Average pain scores and narcotic use are significantly lower when compared with a previously published cohort of patients who underwent autologous breast reconstruction with free abdominal tissue transfer ( P < 0.05). Average antiemetic use was lower in the O-FAFF group compared with the control group: 3.5 versus 4.8 doses ( P = 0.6). Hospital length of stay was 3.0 days (±0.0 days). No complications were noted (0%). Patients were universally satisfied with their reconstructive outcome (100%). CONCLUSIONS: The O-FAFF is proven to be a viable method of autologous breast reconstruction. Early series of patients undergoing O-FAFF reconstruction suggest a lower donor site morbidity as demonstrated by lower postoperative pain scores and lower consumptions of narcotic pain medications.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Deptula P, Zak Y, Dua M, et al. Minimizing Postoperative Pain in Autologous Breast Reconstruction With the Omental Fat-Augmented Free Flap. Ann Plast Surg. 2022. PMID: 35180753. doi:10.1097/SAP.0000000000003084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。